Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Brazil
  4. Bolsa de Valores de Sao Paulo
  5. Fleury S.A.
  6. Summary
    FLRY3   BRFLRYACNOR5

FLEURY S.A.

(FLRY3)
  Report
End-of-day quote. End-of-day quote Bolsa de Valores de Sao Paulo - 07/30
23.36 BRL   -2.91%
07/29FLEURY S A : Earnings Release - 2Q21
PU
07/29FLEURY S A : Financial Statements - 2Q21
PU
06/24FLEURY S A : Comunicado ao Mercado
PU
 SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Bolsa De Valores De Sao P…
07/26/2021 07/27/2021 07/28/2021 07/29/2021 07/30/2021 Date
24.13 23.91 24.33 24.06 23.36 Last
1384900 1183200 1196400 1502700 2393400 Volume
-1.47% -0.91% +1.76% -1.11% -2.91% Change
Estimated financial data (e)
Sales 2021 3 466 M 665 M 665 M
Net income 2021 340 M 65,3 M 65,3 M
Net Debt 2021 1 655 M 318 M 318 M
P/E ratio 2021 21,3x
Yield 2021 3,70%
Sales 2022 3 694 M 709 M 709 M
Net income 2022 368 M 70,6 M 70,6 M
Net Debt 2022 1 635 M 314 M 314 M
P/E ratio 2022 19,2x
Yield 2022 4,10%
Capitalization 7 391 M 1 435 M 1 418 M
EV / Sales 2021 2,61x
EV / Sales 2022 2,44x
Nbr of Employees 15 000
Free-Float 57,2%
More Financials
Company
Fleury S.A. specializes in clinical diagnosis, treatment and analysis services. At the end of 2018, the group operated a network of 187 patient care centers and 23 hospital centers under Fleury, Weinmann, Clínica Felipe Mattoso, a +, Labs a + and Diagnoson a + brands. 
More about the company
Ratings of Fleury S.A.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
B+
More Ratings
All news about FLEURY S.A.
07/29FLEURY S A : Earnings Release - 2Q21
PU
07/29FLEURY S A : Financial Statements - 2Q21
PU
06/24FLEURY S A : Comunicado ao Mercado
PU
04/30Fleury to Seek Acquisitions
CI
04/29FLEURY S A : Financial Statements - 1Q21
PU
04/29Fleury S.A. Reports Earnings Results for the First Quarter Ended March 31, 20..
CI
02/25Fleury S.A. Reports Earnings Results for the Full Year Ended December 31, 202..
CI
02/16Brazil's overwhelmed healthcare system spawns bonanza for dealmakers
RE
02/16Brazil's overwhelmed healthcare system spawns bonanza for dealmakers
RE
2020Fleury S.A. completed the acquisition of CIP - Centro de Infusões Pacaembu LT..
CI
2020Fleury S.A. entered into a purchase and sale agreement to acquire CIP - Centr..
CI
2020Fleury S.A. Reports Earnings Results for the Third Quarter Ended September 30..
CI
2020FLEURY S.A. : 3rd quarter results
CO
2020Fleury S.A. Announces Audited Consolidated and Parent Earnings Results for th..
CI
2020FLEURY S.A. : 1st quarter results
CO
More news
News in other languages on FLEURY S.A.

- No features available -

More news
Chart FLEURY S.A.
Duration : Period :
Fleury S.A. Technical Analysis Chart | FLRY3 | BRFLRYACNOR5 | MarketScreener
Technical analysis trends FLEURY S.A.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 12
Last Close Price 23,36 BRL
Average target price 29,89 BRL
Spread / Average Target 28,0%
EPS Revisions
Managers and Directors
Jeane Tsutsui Chief Executive Officer
Fernando Augusto Rodrigues Leão Filho Chief Financial & Legal Officer
Marcio Pinheiro Mendes Chairman
Edgar Gil Rizzatti Head-Medical, Technical & Process
Fernando de Barros Barreto Independent Director
Sector and Competitors